Skip to main content

Clifford Chance

Clifford Chance
Chang-Do Gong

Chang-Do Gong


Chang-Do Gong

Chang-Do Gong is Co-Head of the US M&A practice. He has more than 20 years of experience advising a diverse range of clients, both domestic and international, on their most complex, multijurisdictional M&A deals.

Chang-Do's experience expands across various industries including energy and infrastructure, healthcare and life science, media and technology.

  • Calpine Corporation (NYSE: CPN) in its US$17 billion acquisition by Energy Capital Partners, an energy-focused private equity firm, and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board.
  • Medlmmune, Inc. in its US$15.2 billion acquisition by AstraZeneca plc.
  • Zimmer Holdings, Inc. in its US$14 billion acquisition of Biomet, Inc.; US$3.4 billion unsolicited acquisition of Centerpulse AG and InCentive Capital AG; and US$1.1 billion acquisition of LDR Holding Corporation.
  • Omnicare, Inc. in its US$12.7 billion acquisition by CVS Health, as well as Omnicare's prior US$1.8 billion unsolicited acquisition of NeighborCare Inc. and US$460 million unsolicited acquisition of NCS HealthCare, Inc.
  • IFM Investors in the acquisition by the IFM Global Infrastructure Fund of Buckeye Partners, L.P. (NYSE:BPL), a publicly traded master limited partnership which owns and operates a diversified global network of pipeline assets and midstream logistics solutions, in a take private transaction with a US$10.3 billion enterprise value and US$6.5 billion equity value. The transaction was named "Private Equity Deal of the Year (Over US$10 billion)" by M&A Advisor (2020).
  • Avast plc, the FTSE 100 global leader in digital security and privacy, in its US$9.2 billion merger with NortonLifeLock. Both companies operate in the cybersecurity space and the combined entity should be market-leading.
  • A consortium composed of Brookfield Infrastructure, its institutional partners and GIC, Singapore's sovereign wealth fund, on the US$8.4 billion acquisition of Genesee & Wyoming Inc., a freight railroad owner and operator based in the United States. This transaction was named "Private Equity Deal of the Year" by IFLR (2020).
  • LifePoint Health, Inc. in its US$5.6 billion merger with RCCH HealthCare Partners.
  • Sony Corporation of America in its US$4.9 billion acquisition of Metro-Goldwyn-Mayer Inc. with a consortium of acquirors; US$2.2 billion acquisition of EMI Music Publishing with a consortium of acquirors; acquisition of the 50% interest in Sony/ATV Music Publishing LLC held by the Estate of Michael Jackson; and US$2.3 billion acquisition of the equity interests in DH Publishing, L.P. (the parent entity of EMI Music Publishing) held by a group of investors led by Mubadala Investment Company.
  • The Walt Disney Company in its US$4.0 billion acquisition of Marvel Entertainment, Inc.
  • SES Holdings Pte. Ltd., a developer and manufacturer of high-performance hybrid lithium-metal rechargeable batteries for electric vehicles, in its US$3.6 billion business combination with Ivanhoe Capital Acquisition Corp. (NYSE: IVAN), a SPAC focused on electrification of society and industry.
  • Roark Capital Group and its portfolio company Arby's Restaurant Group, in Arby's US$2.9 billion acquisition of Buffalo Wild Wings, Inc.
  • Inspire Brands, Inc., a portfolio company of Roark Capital Group, in its US$2.3 billion acquisition of Sonic Corp.
  • CVC Capital Partners in its US$1.8 billion acquisition of ConvergeOne Holdings, Inc. The transaction was named "M&A Deal of the Year (Over US$1 billion)" and "Information Technology Deal of the Year (Over US$1 billion)" by M&A Advisor (2020).
  • Alimentation Couche-Tard in its US$1.9 billion unsolicited cash tender offer for Casey's General Stores, Inc.
  • CNET Networks, Inc. in its US$1.8 billion acquisition by CBS Corporation.
  • King Pharmaceuticals, Inc. in its US$1.6 billion unsolicited acquisition of Alpharma Inc.
  • An affiliate of Morgan Stanley Infrastructure in its US$1.3 billion acquisition of SpecialtyCare, Inc., a leading national platform with an established network for providing outsourced clinical services to hospital operating rooms and provider of perfusion, intraoperative neuromonitoring and surgical services.
  • Roivant Sciences in its US$1.1 billion equity financing from SoftBank Vision Fund and several private M&A transactions and joint ventures.
  • Avast Software, an industry-leading maker of security software, in its US$1.3 billion acquisition of AVG Technologies N.V.
  • Suzhou Dongshan Precision Manufacturing Co. Ltd. in its US$610 million acquisition of Multi- Fineline Electronix Inc.
  • Qatar Investment Authority in its US$550 million acquisition of a minority investment in Oryx Midstream Services from an affiliate of Stonepeak Infrastructure Partners.
  • Sony Corporation of America, a subsidiary of Sony Corporation, in its US$400 million investment in Bilibili Inc., a China-based provider of online entertainment services.
  • Baxter International Inc. (NYSE: BAX) in its US$350 million acquisition of the Seprafilm adhesion barrier device and related assets from SanofiS.A. (NASDAQ: SNY).
  • Morgan Stanley Infrastructure Inc. in its acquisition of Seven Seas Water Corp., AquaVenture Holdings Inc. and AquaVenture Holdings Curacao N.V. from AI Aqua (Luxembourg) S.a.r.l, a company owned by Advent International Corporation.
  • The Special Committee of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) in its sale to a consortium comprised of certain members of CBMG management, shareholders and financial sponsors.

*Matters prior to joining Clifford Chance

News and client work

View all news and client work featuring Chang-Do Gong

Contact details

Career and qualifications

  • Yonsei University (BA, political science) 1990
  • Yonsei University, Graduate School of International Studies (MA) 1996
  • Northwestern University School of Law (JD) 1999
  • Admitted as an Attorney-at-Law in New York 2002
  • Joined Clifford Chance as Partner 2024

Professional bodies

  • Leading Dealmakers in America, Lawdragon 500 2024
  • Leading Individual for M&A, Lawdragon 500 Leading Dealmakers in America, 2022
  • Leading Individual for M&A in the United States, Euromoney, 2022
  • Client Choice Award for New York M&A, Lexology 2020